# 21 CFR 312.3 Definitions and interpretations.

21 CFR 312.3 Definitions and interpretations., “Definitions and interpretations”, is a CFR section of [21 CFR Part 312, Subpart A—General Provisions](https://ontology.bommaritollc.com/id/01a0f094-b5eb-7044-ac97-262d679bc022); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f094-c48d-7311-98ea-d76ee37e8fc3>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter D—DRUGS FOR HUMAN USE](https://ontology.bommaritollc.com/id/01a0f094-b5e4-722f-99b0-5c1856aef2a9) › [21 CFR Part 312—Investigational new drug application](https://ontology.bommaritollc.com/id/01a0f094-b84c-75c3-a0c0-d388d85f1044) › [21 CFR Part 312, Subpart A—General Provisions](https://ontology.bommaritollc.com/id/01a0f094-b5eb-7044-ac97-262d679bc022)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 21 CFR 312.3](https://ontology.bommaritollc.com/id/01a0f094-c48e-7774-ad9a-3cd4dbcc4192)
- `eli:cites`:
  - [Chapter 9—Federal Food, Drug, and Cosmetic Act](https://ontology.bommaritollc.com/id/01a0f06c-cb91-72e0-858b-060e8c845f23)
  - [21 CFR Part 56—Institutional Review Boards](https://ontology.bommaritollc.com/id/01a0f094-b7f2-72a4-82d6-ac180848fce4)
  - [21 CFR 56.102 Definitions.](https://ontology.bommaritollc.com/id/01a0f094-bbe8-7440-a677-059c46d4f553)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-c48d-7311-98ea-d76d559a7113)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-e310-7376-a8a8-97a6eb843e56)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d0-c4d4-7460-9fb5-f3d0852c5f2c)
  - [evidence from https://www.govinfo.gov/link/cfr/21/312?sectionnum=3&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-67ad-70a6-8831-867eca473854)
- `schema:isPartOf`: [21 CFR Part 312, Subpart A—General Provisions](https://ontology.bommaritollc.com/id/01a0f094-b5eb-7044-ac97-262d679bc022)
- `schema:legislationIdentifier`: 21 CFR 312.3
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Definitions and interpretations
- `schema:url`: [https://www.govinfo.gov/link/cfr/21/312?sectionnum=3&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/21/312?sectionnum=3&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 CFR 312.3 Definitions and interpretations.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/21/312?sectionnum=3&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (6; `eli:cites`):
  - [15 CFR Supplement No. 1 to Part 774 The Commerce Control List](https://ontology.bommaritollc.com/id/01a0ee1f-ceed-71b7-b83f-bab1c1f267bb)
  - [21 CFR 300.200 Annual summary requirements under the Right to Try Act.](https://ontology.bommaritollc.com/id/01a0f094-c46e-75b9-b5fd-a73e0e8b7091)
  - [21 CFR 312.120 Foreign clinical studies not conducted under an IND.](https://ontology.bommaritollc.com/id/01a0f094-c4b2-76f2-9c7d-bef6032144ab)
  - [21 CFR 314.50 Content and format of an NDA.](https://ontology.bommaritollc.com/id/01a0f094-c4bc-7545-b254-0ac4503aaeb2)
  - [42 CFR 11.10 What definitions apply to this part?](https://ontology.bommaritollc.com/id/01a0f0b4-2ed3-775e-990a-e0c7ff53d07d)
  - [42 U.S.C. 282 Director of National Institutes of Health](https://ontology.bommaritollc.com/id/01a0f07c-da6f-7067-961a-ab05df754c84)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-c48d-7311-98ea-d76ee37e8fc3.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-c48d-7311-98ea-d76ee37e8fc3.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-c48d-7311-98ea-d76ee37e8fc3.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-c48d-7311-98ea-d76ee37e8fc3)
Cite as: 21 CFR 312.3 Definitions and interpretations.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-c48d-7311-98ea-d76ee37e8fc3
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
